MRX

National Philanthropic Trust Names Linda K. Myers Chair of the Board of Trustees

Retrieved on: 
Tuesday, April 9, 2024
Finance, Consulting, Banking, Accounting, Professional Services, Philanthropy, Fund Raising, Other Philanthropy, Foundation, Chambers and Partners, Georgetown University Law Center, LCI, Gen, Audit, Woman, NPT, Inode, Trustee, National Philanthropic Trust, MRX, University, Lyric, Saint Ignatius College, Lyric Opera of Chicago, Compensation, Field, Chicago Shakespeare Theater, Retirement, Acquisition, Corporate governance, Kirkland & Ellis, Kirkland, Nursing

National Philanthropic Trust (NPT), the largest national, independent public charity that manages donor-advised funds (DAFs), and one of the largest grantmaking organizations in the world, is pleased to announce Linda K. Myers has been named chair of NPT’s Board of Trustees.

Key Points: 
  • National Philanthropic Trust (NPT), the largest national, independent public charity that manages donor-advised funds (DAFs), and one of the largest grantmaking organizations in the world, is pleased to announce Linda K. Myers has been named chair of NPT’s Board of Trustees.
  • She has served as vice chair of NPT’s Board of Trustees and chair of the Compensation and Human Resources Committee.
  • “Linda’s extensive experience in law, business, and governance, along with her lifelong dedication to philanthropy, is an excellent foundation for her to be NPT’s board chair,” said Eileen Heisman, CEO of National Philanthropic Trust.
  • “Linda joined NPT’s Board of Trustees in the early days of the pandemic and quickly became a strategic voice on the board and in her committee leadership.

Generative AI Innovation Drives Another Year of Record Growth for Discuss

Retrieved on: 
Monday, February 5, 2024
Momentum, Jinn, Research, Business intelligence, SVP, MRX, Data analysis, Diageo, Conversation, Qualitative research, Record, Analytics

Discuss was the first MRX company to integrate generative AI-based tools into its platform in early 2023.

Key Points: 
  • Discuss was the first MRX company to integrate generative AI-based tools into its platform in early 2023.
  • The Discuss suite of generative AI tools called Genie , eliminates the many frictions and obstacles inherent to the unstructured nature of qualitative research, including creating summary reports from hours of interviews in a matter of seconds.
  • “Generative AI is ushering in a new era for market research that our industry hasn’t experienced in years.
  • And, for the second consecutive year, Discuss was named a winner in the Analytics and Business Intelligence category of APPEALIE SaaS Awards .

EQS-News: Challenging market, strong results: Mister Spex confirms guidance with 6% revenue growth and positive adjusted EBITDA

Retrieved on: 
Monday, February 5, 2024
Growth, MRX, LFL, Communication, Spex, AOV, Pharmaceutical industry

This growth is within the projected guidance range of mid-high single-digit growth.

Key Points: 
  • This growth is within the projected guidance range of mid-high single-digit growth.
  • The adjusted EBITDA is expected to be in line with the guidance range, reflecting a positive adjusted EBITDA margin in the low single-digit percentage.
  • In the fourth quarter, revenue increased by 7% year-on-year, driven by a robust 10% growth in the Germany segment.
  • Mister Spex sustained its momentum in growth by further enhancing the Average Order Value (AOV), achieving a strong 10% increase.

Ossia Announces 6 Wireless Power Partners To Be Showcased at 2024 CES

Retrieved on: 
Wednesday, January 3, 2024
Cloud, Atmosphere, Fear, PIN, LED, Heat, POC, Igloo, MRX, Light, CES, AA, Hertz, Video game

BELLEVUE, Wash., Jan. 3, 2024 /PRNewswire/ -- Ossia Inc., the company behind FCC-approved Cota® Real Wireless Power™ — the patented technology that delivers power over-the-air, at a distance, and without the need for line-of-sight — today announced that six of its partners will be demonstrating devices that leverage Cota Real Wireless Power live at CES, the largest technology convention and exhibition in the world.

Key Points: 
  • Toyoda Gosei will be showcasing the AA Cota Forever Battery, which enables a retrofit for small devices, a first step toward adopting Real Wireless Power™.
  • MRx empowers even the most non-technical people to open a device and connect a few wires and experience Cota Real Wireless Power.
  • Groundbreaking Cota Real Wireless Power technology automatically delivers power to Senza over air and at a distance.
  • Attendees of the CES conference will see this end-to-end wireless system in action through Ossia's forward-thinking partners.

EQS-News: Mister Spex continues to outgrow the market and to improve its profitability in Q3 – guidance for 2023 confirmed

Retrieved on: 
Thursday, December 14, 2023
FY, Contact, Weather, MRX, Environment, Spex, EBITDA, SE, Growth, Pharmaceutical industry, Retail

In the third quarter of 2023, Mister Spex SE recorded a revenue growth of +2%, once again outperforming the market in a challenging environment.

Key Points: 
  • In the third quarter of 2023, Mister Spex SE recorded a revenue growth of +2%, once again outperforming the market in a challenging environment.
  • The quarter has been impacted by a number of external headwinds, such as reduced consumer sentiment and unseasonal weather patterns.
  • This has overshadowed the positive developments in the key categories where Mister Spex focuses on, namely prescription glasses and sunglasses.
  • Mirko Caspar, Co-CEO of Mister Spex SE: “We attach great importance to high-quality brands in the luxury and independent segment.

Prime Therapeutics and Magellan Rx to present three managed care pharmacy research studies at AMCP Nexus

Retrieved on: 
Monday, October 16, 2023
Nexus, Haemophilia, ABR, Bleeding, Weight loss, Cytokine release syndrome, Radiation, Pharmacotherapy, Non-Hodgkin lymphoma, AMCP, Lymphoma, Cancer, Diabetes, Patient, MRX, Therapy, B-cell lymphoma, DPP4, PMPM, Documentation, Canadian Aviation Regulations, CAR, CRS, Pharmacy, Overalls, Doctor of Pharmacy, Research, NHL, Toxic epidermal necrolysis, Nursing, Pharmaceutical industry, Health insurance, Vaccine, Birth control

EAGAN, Minn., Oct. 16, 2023 /PRNewswire/ -- Prime Therapeutics LLC/Magellan Rx Management (Prime/MRx) will present three research studies at the 2023 Academy of Managed Care Pharmacy (AMCP) Nexus event, October 16-19 in Orlando, Fla.

Key Points: 
  • EAGAN, Minn., Oct. 16, 2023 /PRNewswire/ -- Prime Therapeutics LLC / Magellan Rx Management (Prime/MRx) will present three research studies at the 2023 Academy of Managed Care Pharmacy (AMCP) Nexus event , October 16-19 in Orlando, Fla.
    Health outcomes teams from the organization used integrated medical and pharmacy claims data to evaluate real-world drug utilization, managed care pharmacy programs, and associated costs of care for a range of conditions, including diabetes, lymphoma, and hemophilia.
  • This study illustrates the impact of comprehensive hemophilia care and managed care strategies which led to more than $3.7 million in cost avoidance.
  • More information about these presentations can be found on Prime Therapeutics' events page or the AMCP Nexus website .
  • And for further insights on the studies noted above, visit Prime Therapeutics' newsroom .

PRIME THERAPEUTICS/MAGELLAN RX EXPANDS PARTNERSHIP WITH MHK TO MANAGE MEMBER ENROLLMENT WITH MARKETPROMINENCE TECHNOLOGY

Retrieved on: 
Thursday, October 5, 2023
Partnership, Trade, Organization, Software as a service, Forest Law Enforcement and Governance Program, MHK, MRX, CMS, Medicare, Growth, SVP, Pharmacy benefit management, Blue Cross Blue Shield Association, Health insurance, Nursing

TAMPA, Fla., Oct. 5, 2023 /PRNewswire/ -- MHK, a leading healthcare technology provider and part of the Hearst Health network, announced today that Prime Therapeutics LLC/Magellan Rx (Prime/MRx) expanded its partnership with MHK, adding on the MarketProminence® SaaS technology platform.

Key Points: 
  • TAMPA, Fla., Oct. 5, 2023 /PRNewswire/ -- MHK , a leading healthcare technology provider and part of the Hearst Health network, announced today that Prime Therapeutics LLC/Magellan Rx (Prime/MRx) expanded its partnership with MHK, adding on the MarketProminence® SaaS technology platform.
  • The organizations began their partnership in 2020 with the selection of the MHK CareProminence® platform for Medicare pharmacy management.
  • Expanding upon this relationship, Prime/MRx will now use MHK's MarketProminence technology to manage member enrollment, premium billing and financial reconciliation to support the growth of its health plan business, specifically Employer Group Waiver Plans.
  • We look forward to helping their team implement a best-in-class member enrollment program to support the growth of their health plan business," said Conor Bagnell, President of MHK.

Radius Global Market Research Appoints Ed Keller to its Board of Directors

Retrieved on: 
Wednesday, September 27, 2023
Software as a service, University, Top 50 Influential Women in Engineering, Marketing Research Institute International, Creator economy, Curriculum, Radius, Research, MRX, Acquisition, USC Annenberg School for Communication and Journalism, Communication, Social, Book, Widener University Commonwealth Law School, Management

NEW YORK, Sept. 27, 2023 /PRNewswire/ -- Radius Global Market Research, a leading global marketing research and insights firm, announced the appointment of Ed Keller, CEO of the Keller Advisory Group, to its board of directors. Keller brings a wealth of industry knowledge into Radius's growth and development initiatives.

Key Points: 
  • NEW YORK, Sept. 27, 2023 /PRNewswire/ -- Radius Global Market Research, a leading global marketing research and insights firm, announced the appointment of Ed Keller, CEO of the Keller Advisory Group, to its board of directors.
  • As Radius embarks on its next phase of expansion, Keller's deep experience will bring a fresh perspective to the Radius board of directors.
  • Chip Lister, Managing Director of Radius Global Market Research, said, "We are honored to welcome Ed Keller to our board of directors.
  • He serves as Executive Director at the Market Research Institute International offering guidance on the organization's online market research training and development curriculum.

EQS-News: Mister Spex announces robust H1 2023 performance with 8% revenue growth, a 293 basis points gross margin improvement and the return to a positive adjusted EBITDA

Retrieved on: 
Thursday, August 31, 2023
Yoy, H1, Growth, Spex, EBITDA, Face, Marketing, MRX, Beauty salon, Pharmaceutical industry, Video game, Retail, Cryptocurrency

Mister Spex announces robust H1 2023 performance with 8% revenue growth, a 293 basis points gross margin improvement and the return to a positive adjusted EBITDA

Key Points: 
  • Mister Spex announces robust H1 2023 performance with 8% revenue growth, a 293 basis points gross margin improvement and the return to a positive adjusted EBITDA
    The issuer is solely responsible for the content of this announcement.
  • This revenue surge was assisted by the opening of six new stores in 2023, extending the company’s retail footprint to 74 outlets.
  • The physical retail network achieved an 11% like-for-like growth [a] in H1 2023 compared to the same period last year.
  • Management expects revenue growth in the mid to high single-digit percentage range and a positive adjusted EBITDA margin in the low single-digit percentage range.

Magellan Rx Pharmacy LLC earns URAC Reaccreditation in Specialty Pharmacy

Retrieved on: 
Monday, August 28, 2023
Pharmaceutical Services Negotiating Committee, Accreditation, Education, Pharmacy, MRX, Risk management, International Cataloguing Standards Committee, Hospital, Specialty pharmacy, Patient, Physician, Patient safety, URAC, Therapy, Conditional sentence, Nursing, Health care

EAGAN, Minn., Aug. 28, 2023 /PRNewswire/ -- Prime Therapeutics LLC (Prime)/Magellan Rx (MRx) is proud to announce that Magellan Rx Pharmacy, LLC (Magellan Rx), MRx's specialty pharmacy, has earned URAC reaccreditation for Specialty Pharmacy.

Key Points: 
  • EAGAN, Minn., Aug. 28, 2023 /PRNewswire/ -- Prime Therapeutics LLC (Prime)/Magellan Rx (MRx) is proud to announce that Magellan Rx Pharmacy, LLC (Magellan Rx), MRx's specialty pharmacy, has earned URAC reaccreditation for Specialty Pharmacy.
  • URAC is the independent leader in promoting health care quality by setting high standards for clinical practice, consumer protections, performance measurement, operations infrastructure and risk management.
  • By achieving this status, MRx demonstrates commitment to quality care, enhanced processes, patient safety and improved outcomes.
  • Given the complicated nature of chronic disease, pharmacies like Magellan Rx Pharmacy do much more than simply fill a prescription.